Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Covance
Special Reports
The top 10 medtech M&A deals of 2021
Many of 2021's medtech acquisitions were fueled by pandemic windfalls, driven by a year of roller-coaster demand for coronavirus tests and supplies.
Conor Hale
,
Andrea Park
Jan 18, 2022 3:00am
GSK vaccine exec hits the exit—Chutes & Ladders
Jan 22, 2021 9:30am
Covance boosts Franklin to lead its cell and gene therapy unit
Jan 20, 2021 7:05am
The rise and rise of the virtual trial model
Dec 22, 2020 7:00am
Covance starting to rebound, but trial business struggles
Oct 27, 2020 9:00am
Covance to 'transform' into a decentralized CRO
Oct 20, 2020 8:10am
